SECURITIES AND EXCHANGE COMMISSION
                              Washington, DC 20549



                                  SCHEDULE 13G

                    Under the Securities Exchange Act of 1934

                               (Amendment No. 6)*

                                 Isolagen, Inc.
                                (Name of Issuer)


                    Common Stock, par value $0.001 per share
                         (Title of Class of Securities)


                                    46488N103
                                 (CUSIP Number)

                                 July 9, 2009
             (Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:

         |_|      Rule 13d-1(b)

         |X|      Rule 13d-1(c)

         |_|      Rule 13d-1(d)

*The  remainder of this cover page shall be filled out for a reporting  person's
initial filing on this form with respect to the subject class of securities, and
for any  subsequent  amendment  containing  information  which  would  alter the
disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the  Securities  Exchange  Act of
1934 ("Act") or otherwise  subject to the liabilities of that section of the Act
but  shall be  subject  to all other  provisions  of the Act  (however,  see the
Notes).







                                  SCHEDULE 13G
CUSIP NO. 46488N103                                                      2 of 6

                      NAMES OF REPORTING PERSONS
                      I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (Entities
                      Only)
         1
                      Michael A. Roth and Brian J. Stark, as joint filers
                      pursuant to Rule 13d-1(k)

         2            CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP  (a)  |X|
                                                                        (b)  |_|

         3            SEC USE ONLY

         4            CITIZENSHIP OR PLACE OF ORGANIZATION

                      United States of America

          NUMBER OF                    SOLE VOTING POWER
                                 5
            SHARES                     0

         BENEFICIALLY                  SHARED VOTING POWER
                                 6
        OWNED BY EACH                  2,823,135  shares  of  Common  Stock (See
                                       Item 4)

          REPORTING                    SOLE DISPOSITIVE POWER
                                 7
         PERSON WITH                    0

                                       SHARED DISPOSITIVE POWER
                                 8
                                       2,823,135  shares  of  Common  Stock (See
                                       Item 4)

                      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
                      PERSON
         9
                      2,823,135 shares of Common Stock (See Item 4)

                      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
                      CERTAIN SHARES                                         |X|
         10

                      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
         11
                      6.6% (See Item 4)

                      TYPE OF REPORTING PERSON
         12
                      IN




Item 1(a).        Name of Issuer:

                  Isolagen, Inc. (the "Issuer").

Item 1(b).        Address of Issuer's Principal Executive Offices:

                  405 Eagleview Boulevard
                  Exton, Pennsylvania 19341

Items 2(a),
(b) and (c).      Name of Persons Filing,  Address of Principal  Business Office
                  and Citizenship:

                  This  Amendment  No. 6 to  Schedule  13G is  being  filed  on
                  behalf  of  Michael  A. Roth  and  Brian J.  Stark,  as joint
                  filers   (collectively,   the  "Reporting   Persons").

                  The   Reporting  Persons   have  entered  into a Joint Filing
                  Agreement,  a copy of which is filed with  this Amendment No.
                  6 to  Schedule  13G  as  Exhibit  1,  pursuant  to which  the
                  Reporting  Persons have agreed to file this  Amendment  No. 6
                  to Schedule 13G jointly in accordance with the  provisions of
                  Rule  13d-1(k) of  the  Securities  Exchange Act of 1934,  as
                  amended (the "Exchange Act").

                  The principal  business  office of  the Reporting  Persons is
                  3600 South Lake Drive, St. Francis,  WI  53235. The Reporting
                  Persons are citizens of the United States of America.

Item  2(d).       Title of Class of Securities:

                  Common  Stock,  par value $0.001 per share (the "Common
                  Stock")

Item 2(e).        CUSIP Number:

                  46488N103

Item 3.           Not applicable.

Item 4.           Ownership.

                  (a)      Amount beneficially owned:

                           2,823,135 shares of Common Stock*

                  (b)      Percent of class:

                           Based   on   42,820,380  shares   of   Common   Stock
                           outstanding as of  May  13,  2009  (as  set  forth in
                           the  Issuer's  10-Q  for the  period  ended March 31,
                           2009),   the  Reporting  Persons  hold  approximately
                           6.6%* of  the issued and  outstanding Common Stock of
                           the Issuer.

                  (c)      Number of shares to which such person has:

                           (i)      Sole power to vote or direct the vote:  0

                           (ii)     Shared power to vote or direct the vote:
                                    2,823,135 shares of Common Stock*

                           (iii)    Sole power to dispose or to direct the
                                    disposition of: 0

                           (iv)     Shared power to dispose of or direct the
                                    disposition of: 2,823,135 shares of Common
                                    Stock*

                    *The  Reporting  Persons  beneficially  own an  aggregate of
                    2,823,135  shares of Common Stock.  The foregoing  amount of
                    Common Stock and percentage ownership represent the combined
                    indirect holdings of Michael A. Roth and Brian J.Stark.

                    All of the  foregoing  represents an  aggregate of 2,823,135
                    shares of Common Stock held  directly by SF Capital Partners
                    Ltd. ("SF  Capital"). The Reporting Persons are the Managing
                    Members of Stark Offshore Management LLC ("Stark Offshore"),
                    which  acts as  investment  manager  and has  sole  power to
                    direct the management of SF Capital. Through Stark Offshore,
                    the Reporting  Persons possess voting and dispositive  power
                    over  all  of  the  foregoing  shares.  Therefore,  for  the
                    purposes of Rule 13d-3 under the Exchange Act, the Reporting
                    Persons  may be deemed to be the  beneficial  owners of, but
                    hereby disclaim such beneficial  ownership of, the foregoing
                    shares.



Item 5.           Ownership of Five Percent or Less of a Class.

                  Not applicable

Item 6.           Ownership of More than Five Percent on Behalf of Another
                  Person.

                  Not applicable

Item 7.           Identification  and  Classification  of  the  Subsidiary Which
                  Acquired  the  Security  Being  Reported By the Parent Holding
                  Company.

                  Not applicable

Item 8.           Identification and Classification of Members of the Group.

                  Not applicable

Item 9.           Notice of Dissolution of a Group.

                  Not applicable


Item 10.          Certification.

                  By signing  below I certify that,  to the best of my knowledge
                  and  belief,  the  securities  referred  to  above  were   not
                  acquired  and  are not  held for the  purpose  of or with  the
                  effect of changing  or  influencing  the control of the issuer
                  of the  securities and were  not  acquired and are not held in
                  connection  with  or  as  a  participant  in  any  transaction
                  having that purpose or effect.



                                    SIGNATURE

        After  reasonable  inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true,  complete and
correct.

Dated: July 17, 2009



                                           /s/ Michael A. Roth
                                           Michael A. Roth



                                           /s/ Brian J. Stark
                                           Brian J. Stark





                                  SCHEDULE 13G
CUSIP NO. 46488N103

                                                                      Exhibit 1

                             JOINT FILING AGREEMENT



        In  accordance with  Rule 13d-1(k) under the Securities  Exchange Act of
     1934, as amended,  the  undersigned  agree to the joint filing on behalf of
     each of them of a statement on Schedule 13G (including  amendments thereto)
     with  respect to 2,823,135  shares of Common  Stock of  Isolagen,  Inc. and
     further  agree that this Joint  Filing  Agreement  shall be  included as an
     exhibit to such jointfilings.

       The  undersigned further  agree that each party hereto is responsible for
     the timely  filing of such Schedule 13G and any amendments thereto, and for
     the  completeness  and  accuracy of the information  concerning such  party
     contained therein; provided, however, that no party is  responsible for the
     completeness  or  accuracy  of the  information  concerning any other party
     making  the filing, unless such  party  knows or has reason to believe that
     such information is inaccurate.

       IN WITNESS WHEREOF, the parties have executed this Joint Filing Agreement
     on July 17, 2009.


                                         /s/ Michael A. Roth
                                         Michael A. Roth



                                         /s/ Brian J. Stark
                                         Brian J. Stark